advanced hepatocellular carcinoma - Globe Thesis

Keyword [advanced hepatocellular carcinoma] Result: 101 - 120 \| Page: 6 of 7
101.	Efficacy And Safety Of Hepatic Arterial Infusion Chemotherapy Combined With Lenvatinib And PD-1 Inhibitors For Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
102.	Efficacy Analysis Of Hepatic Arterial Infusion Chemotherapy Enhanced Sorafenib Combined With Camrelizumab In The Treatment Of Advanced Hepatocellular Carcinoma
103.	Meta Analysis Of The Efficacy Of Immunotherapy Combined With Targeted Drugs For Intermediate To Advanced Hepatocellular Carcinoma
104.	Efficacy And Safety Of Targeted Immunotherapy Combined With Local Therapy In Advanced Hepatocellular Carcinoma
105.	Efficacy Of FOLFOX-HAIC Combined With Targeted Therapy And Immunotherapy For Advanced Hepatocellular Carcinoma
106.	Comparison Of Efficacy And Safety Of Regorafenib With Or Without PD-1 Inhibitors In The Second-line Treatment Of Advanced Hepatocellular Carcinoma
107.	The Research Of Serum Granzyme B Predicting The Efficacy Of Targeted Drugs Combined With PD-1 Inhibitor For Advanced Hepatocellular Carcinoma
108.	Efficacy And Safety Of First-Line Treatment Options For Advanced Hepatocellular Carcinoma:A Network Meta-Analysis
109.	Prognostic Exploration Of PD-L1 Positive Circulating Tumor Cells In Advanced Hepatocellular Carcinoma Receiving Radiotherapy Combined With PD-1 Inhibitors And Targeted Drugs
110.	Correlation Analysis Of Lymphocyte Subsets Characteristics With The Efficacy Of Comprehensive Treatment For Patients With Intermediate To Advanced Hepatocellular Carcinoma
111.	Correlation Of Peripheral Blood Parameters On The Prognosis And Curative Effect Of Advanced Hepatocellular Carcinoma Treated With Immune Check-point Inhibitors
112.	Clinical Study Of Stereotactic Body Radiotherapy Combined With Lenvatinib For Advanced Hepatocellular Carcinoma
113.	Analysis Of The Clinical Effect Of TACE Combined With Lenvatinib And PD-1 Inhibitor On Advanced Hepatocellular Carcinoma
114.	Analysis Of The Effectiveness And Safety Of TACE-HAIC Combined With Targeted And PD-1 Inhibitor For Intermediate And Advanced Hepatocellular Carcinoma
115.	Application Of 3-phase Perfusion CT Parameters In Evaluating Early-treatment Response To Transcatheter Arterial Chemoembolization Of Advanced Hepatocellular Carcinoma
116.	Efficacy And Safety Of TACE Combined With Lenvatinib And Camrelizumab In The Treatment For Intermediate Or Advanced Hepatocellular Carcinoma
117.	A Retrospective Study Of Single-center Conversion Therapy For Advanced Hepatocellular Carcinoma
118.	Clinical Efficacy And Safety Analysis Of HAIC Combined With PD-1 Inhibitor And Sorafenib In The Treatment Of Intermediate And Advanced Hepatocellular Carcinoma
119.	Clinical Efficacy Observation Of Yangzheng Xiaoji Capsules Combined With Camrelizumab And Apatinib In The Treatment Of Middle And Advanced Hepatocellular Carcinoma
120.	Efficacy And Prognosis Of Camrelizumab Combined With Apatinib In The Treatment Of Advanced Hepatocellular Carcinoma
<<First <Prev Next> Last>> Jump to